Kayla St Claire, MD
Dermatopathology · Chicago, ILNPI 1487113270
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,883 of the $4,395 with a category attached, or 65.6%. 19 manufacturers reported payments, led by Sanofi at 42.4% of the total. Reporting peaked in 2023 at $2,322 and has fallen 93.1% since, to $161 in 2025.
Across 90 payments — averaging $48.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$2K
- AbbVie$734
- Regeneron Healthcare Solutions, Inc.$484
- Lilly USA, LLC$224
- Sun Pharmaceutical Industries Inc.$189
- UCB, Inc.$170
- plus $732 from 13 others
What the payments were for
- Consulting fees$1,51234%
- Food & beverage$2,88366%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 12 | $1,863 |
| AbbVie | 28 | $734 |
| Regeneron Healthcare Solutions, Inc. | 10 | $484 |
| Lilly USA, LLC | 6 | $224 |
| Sun Pharmaceutical Industries Inc. | 5 | $189 |
| UCB, Inc. | 4 | $170 |
| Janssen Scientific Affairs, LLC | 1 | $135 |
| Krystal Biotech Inc | 1 | $120 |
| Helsinn Therapeutics (U.S.), Inc. | 6 | $96 |
| Boehringer Ingelheim | 2 | $73 |
| E.r. Squibb & Sons, L.L.C. | 3 | $62 |
| Johnson & Johnson | 3 | $50 |
| Biofrontera Inc. | 2 | $49 |
| Arcutis Biotherapeutics, Inc. | 2 | $44 |
| Amgen | 1 | $30 |
| Novartis | 1 | $23 |
| LEO Pharma Inc. | 1 | $22 |
| Pfizer | 1 | $15 |
| Almirall LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few dermatopathology providers in Illinoisto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 233 | $4,130 |
| Clobetasol Propionate | 117 | $2,499 |
| Triamcinolone Acetonide | 97 | $1,368 |
| Ammonium Lactate | 80 | $1,213 |
| Desonide | 20 | $800 |
| Fluorouracil | 12 | $690 |
| Metronidazole | 12 | $542 |
| Clindamycin Phosphate | 28 | $534 |
| Betamethasone Dipropionate | 15 | $506 |
| Ciclopirox | 15 | $463 |
| Doxycycline Hyclate | 37 | $443 |
| Hydrocortisone | 75 | $325 |
| Minoxidil | 14 | $186 |
| Fluocinonide | 12 | $173 |
| Nystatin | 11 | $148 |
Paid to pharmacies, not to this prescriber.
Other dermatopathology in Chicago
- Joan GuitartChicago$43K
- Vesna Petronic RosicChicago$11K
- Kyla Price-JaureguiChicago$2K
- Cuong NguyenChicago$413
- Sara Kullberg PearsonChicago$150
- Lohini SundharkrishnanChicago$52
- Brian NickoloffMaywood$116K
- George NahassGlen Carbon$5K
- Carl SoderstromPeoria$385
- Suzanne BirminghamElgin$244
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.